AstraZeneca PLC
Stocks making the biggest moves midday: Oil stocks, Ford, Crocs and more
Check out the companies making headlines in midday trading. Ford Motor — Shares of the carmaker dropped 1% and hit a new 52-week low after the company reported a slight increase in new vehicle sales for the second quarter that missed automotive analysts’ expectations. The company said sales rose 1.8% to 483,688 new vehicles in […]
Read More
Stocks making the biggest moves premarket: Tesla, Occidental Petroleum, Exxon Mobil and more
Check out the companies making headlines before the bell: Tesla (TSLA) – Tesla delivered 254,695 vehicles during the second quarter, down 17.9% from the first quarter and below what analysts had predicted. China’s Covid-19 shutdowns were a key factor in holding back production. Tesla fell 1% in premarket trading. Occidental Petroleum (OXY) – Occidental gained […]
Read More
These low volatility, dividend-paying global stocks are beating the market — and could go higher
From multi-day losing streaks to overnight rallies, it has been a roller coaster ride for markets this year. For investors looking to ride out the unpredictability, CNBC PRO has screened for low-volatility stocks with income in the U.S. and beyond, that have outperformed the beaten-down market. Stocks ended last week lower as markets weighed the […]
Read More
Here are Tuesday’s biggest analyst calls: Coinbase, Apple, Amazon, Best Buy, Netflix, Tesla & more
Here are Tuesday’s biggest calls on Wall Street: Benchmark downgrades Netflix to sell from hold Benchmark said in its downgrade of the stock that it’s “skeptical” of a sustained a Netflix recovery. “We have made mild estimate revisions off continued U.S. dollar strength, including vs. the yen and European currencies, that is likely not fully […]
Read More
JPMorgan names its winning and losing global stocks for the rest of the year
Analysts at JPMorgan have picked their likely winners and losers for the second half of 2022, naming stocks set to do well — or badly — when factors such as inflation, bond yields and oil prices are taken into account. The analysts identified several trends for the coming months after a volatile first half that […]
Read More
Cramer’s lightning round: AstraZeneca is a pass
Intuitive Surgical Inc: “ISRG is one of those stocks – you must not look at it on a day-to-day basis. You look at it on a year-to-year basis, that’s how good their machines are.” Banco Santander SA: “I looked at it multiple times to own it for the Charitable Trust. I just can’t summon myself […]
Read More
These global stocks were first-quarter winners and Wall Street sees more upside ahead
These buy-rated stocks from the U.S. and beyond had a strong start to the year and are expected to continue to rise. Source
Read More
Some of the first quarter’s biggest losers could be the biggest steals, Jim Cramer says
Investors should consider purchasing stock of the first quarter’s biggest losers if the market shows signs of recovering on its own, CNBC’s Jim Cramer said Monday. “This market’s screaming that we’re headed for a [Federal Reserve]-mandated slowdown, that could possibly become a Fed-mandated recession,” the “Mad Money” host said. “If we get more signs that […]
Read More
AstraZeneca takes stake in a start-up that helps doctors conduct clinical trials virtually
Medical syringes and small figurines of people are seen in front of the AstraZeneca logo displayed on a screen. On Saturday, March 26, 2021, in Dublin, Ireland. NurPhoto | NurPhoto | Getty Images LONDON — AstraZeneca said Wednesday it has invested in Huma, a U.K.-based medical technology start-up, as part of a broader commercial tie-up […]
Read More
Covid was declared a pandemic two years ago and now we’re finally moving on — but public health experts say it’s not over
Medical staff treat a coronavirus disease (COVID-19) patient in the Intensive Care Unit (ICU) at the Providence Mission Hospital in Mission Viejo, California, January 25, 2022. Shannon Stapleton | Reuters LONDON — With war raging between Russia and Ukraine, the world’s battle against the coronavirus has been largely sidelined and the second anniversary of Covid-19 […]
Read More